Progesterone protects against bisphenol a-induced arrhythmias in female rat cardiac myocytes via rapid signaling

Endocrinology

Volumn 158, Issue 4, 2017, Pages 778-790

  Ma, Jianyong ^a,b   Hong, Kui ^a   Wang, Hong Sheng ^b  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BOVINE SERUM ALBUMIN; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MIFEPRISTONE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLAMBAN; PROGESTERONE; PROTEIN KINASE B; SERINE; THREONINE; WORTMANNIN; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; PHENOL DERIVATIVE; PROTECTIVE AGENT;

ADULT; ANIMAL CELL; ARTICLE; BRAIN CELL; CARDIAC MUSCLE CELL; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECT; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; BENZHYDRYL COMPOUNDS; CALCIUM; ENDOCRINE DISRUPTORS; FEMALE; MYOCYTES, CARDIAC; PHENOLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROGESTERONE; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

EID: 85016806435     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1702     Document Type: Article

References (70)

1. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect. 2010;118(8):1055-1070.
2. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007; 24(2):139-177.
3. Geens T, Aerts D, Berthot C, Bourguignon JP, Goeyens L, Lecomte P, Maghuin-Rogister G, Pironnet AM, Pussemier L, Scippo ML, Van Loco J, Covaci A. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol. 2012;50(10): 3725-3740.
4. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, Vom Saal FS. Endocrine-disrupting chemicals and public health protection: A statement of principles from The Endocrine Society. Endocrinology. 2012;153(9):4097-4110.
5. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293-342.
6. Shankar A, Teppala S, Sabanayagam C. BisphenolAand peripheral arterial disease: Results from the NHANES. Environ Health Perspect. 2012;120(9):1297-1300.
7. Shankar A, Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J Environ Public Health. 2012; 2012:481641.
8. Melzer D, Osborne NJ, Henley WE, Cipelli R, Young A, Money C, McCormack P, Luben R, Khaw KT, Wareham NJ, Galloway TS. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation. 2012;125(12):1482-1490.
9. Melzer D, Gates P, Osborne NJ, Henley WE, Cipelli R, Young A, Money C, McCormack P, Schofield P, Mosedale D, Grainger D, Galloway TS. Urinary bisphenol a concentration and angiographydefined coronary artery stenosis [published correction appears in PLoS One 2012;7(11)]. PLoS One. 2012;7(8):e43378.
10. Posnack NG, Jaimes R III, Asfour H, Swift LM, Wengrowski AM, Sarvazyan N, Kay MW. Bisphenol A exposure and cardiac electrical conduction in excised rat hearts. Environ Health Perspect. 2014;122(4):384-390.
11. Patel BB, Raad M, Sebag IA, Chalifour LE. Lifelong exposure to bisphenol a alters cardiac structure/function, protein expression, and DNA methylation in adult mice. Toxicol Sci. 2013;133(1): 174-185.
12. Aboul Ezz HS, Khadrawy YA, Mourad IM. The effect of bisphenol A on some oxidative stress parameters and acetylcholinesterase activity in the heart of male albino rats. Cytotechnology. 2015; 67(1):145-155.
13. Yan S, Chen Y, Dong M, Song W, Belcher SM, Wang HS. Bisphenol A and 17b-estradiol promote arrhythmia in the female heart via alteration of calcium handling. PLoS One. 2011;6(9):e25455.
14. Yan S, Song W, Chen Y, Hong K, Rubinstein J, Wang HS. Lowdose bisphenol A and estrogen increase ventricular arrhythmias following ischemia-reperfusion in female rat hearts. Food Chem Toxicol. 2013;56:75-80.
15. Gao X, Liang Q, Chen Y, Wang HS. Molecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts. Endocrinology. 2013;154(12):4607-4617.
16. Rajapakse N, Ong D, Kortenkamp A. Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicol Sci. 2001;60(2):296-304.
17. Mlynarcikova A, Macho L, FickovaM. Bisphenol A alone or in combination with estradiol modulates cell cycle- and apoptosisrelated proteins and genes in MCF7 cells. Endocr Regul. 2013; 47(4):189-199.
18. Johnson SA, Painter MS, Javurek AB, Ellersieck MR, Wiedmeyer CE, Thyfault JP, Rosenfeld CS. Sex-dependent effects of developmental exposure to bisphenol A and ethinyl estradiol on metabolic parameters and voluntary physical activity. J Dev Orig Health Dis. 2015;6(6):539-552.
19. Churchwell MI, Camacho L, Vanlandingham MM, Twaddle NC, Sepehr E, Delclos KB, Fisher JW, Doerge DR. Comparison of life-stage-dependent internal dosimetry for bisphenol A, ethinyl estradiol, a reference estrogen, and endogenous estradiol to test an estrogenic mode of action in Sprague Dawley rats. Toxicol Sci. 2014;139(1):4-20.
20. Shyamala G. Roles of estrogen and progesterone in normal mammary gland development insights from progesterone receptor null mutant mice and in situ localization of receptor. Trends Endocrinol Metab. 1997;8(1):34-39.
21. Kodaman PH, Taylor HS. Hormonal regulation of implantation. Obstet Gynecol Clin North Am. 2004;31(4):745-766.
22. Conneely OM, Lydon JP, De Mayo F, O'Malley BW. Reproductive functions of the progesterone receptor. J Soc Gynecol Investig. 2000; 7(1, Suppl)S25-S32.
23. Sunday L, Tran MM, Krause DN, Duckles SP. Estrogen and progestagens differentially modulate vascular proinflammatory factors. Am J Physiol Endocrinol Metab. 2006;291(2):E261-E267.
24. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. AmJ Physiol. 1991;261(4 Pt 2):R1022-R1027.
25. Hanke H, Hanke S, Bruck B, Brehme U, Gugel N, Finking G, Mück AO, Schmahl FW, Hombach V, Haasis R. Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis. 1996;121(1):129-138.
26. Faludi AA, Aldrighi JM, Bertolami MC, Saleh MH, Silva RA, Nakamura Y, Pereira IR, Abdalla DS, Ramires JA, Sousa JE. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis. 2004;177(1):89-96.
27. Kadish AH, Greenland P, Limacher MC, FrishmanWH, Daugherty SA, Schwartz JB. Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol. 2004; 9(4):366-374.
28. Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Rautaharju PM, Liao D, Evans GW, Heiss G. A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: The atherosclerosis risk in communities study. Ann Epidemiol. 2003; 13(7):530-536.
29. Yang PC, Kurokawa J, Furukawa T, Clancy CE. Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: A simulation study. PLOS Comput Biol. 2010;6(1):e1000658.
30. Odening KE, Choi BR, Liu GX, Hartmann K, Ziv O, Chaves L, Schofield L, Centracchio J, ZehenderM, Peng X, Brunner M, Koren G. Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm. 2012;9(5):823-832.
31. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: Synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology. 2002;143(1):205-212.
32. Carroll JC, Rosario ER, Pike CJ. Progesterone blocks estrogen neuroprotection from kainate in middle-aged female rats. Neurosci Lett. 2008;445(3):229-232.
33. Aguirre CC, Baudry M. Progesterone reverses 17beta-estradiolmediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci. 2009;29(3):447-454.
34. Toung TJ, Chen TY, Littleton-Kearney MT, Hurn PD, Murphy SJ. Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab. 2004;24(10):1160-1166.
35. Roesch DM, Keller-Wood M. Progesterone rapidly reduces arterial pressure in ewes. Am J Physiol. 1997;272(1 Pt 2):H386-H391.
36. Minshall RD, Pavcnik D, Browne DL, Hermsmeyer K. Nongenomic vasodilator action of progesterone on primate coronary arteries. J Appl Physiol (1985). 2002;92(2):701-708.
37. Dhote VV, Balaraman R. Gender specific effect of progesterone on myocardial ischemia/reperfusion injury in rats. Life Sci. 2007; 81(3):188-197.
38. Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, Oren RV, Zhu ZI, Clancy CE, Isobe M, Furukawa T. Progesterone regulates cardiac repolarization through a nongenomic pathway: An in vitro patch-clamp and computational modeling study. Circulation. 2007;116(25):2913-2922.
39. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell. 2001;8(2):269-280.
40. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol. 2007;21(2): 359-375.
41. Sanchez AM, FlaminiMI, Genazzani AR, Simoncini T. Effects of progesterone and medroxyprogesterone on actin remodeling and neuronal spine formation. Mol Endocrinol. 2013;27(4): 693-702.
42. Fu XD, Giretti MS, Baldacci C, Garibaldi S, Flamini M, Sanchez AM, Gadducci A, Genazzani AR, Simoncini T. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One. 2008;3(7):e2790.
43. Sagare-Patil V, Vernekar M, Galvankar M, Modi D. Progesterone utilizes the PI3K-AKT pathway in human spermatozoa to regulate motility and hyperactivation but not acrosome reaction. Mol Cell Endocrinol. 2013;374(1-2):82-91.
44. Ballaré C, Vallejo G, Vicent GP, Saragüeta P, Beato M. Progesterone signaling in breast and endometrium. J Steroid Biochem Mol Biol. 2006;102(1-5):2-10.
45. Zheng S, Huang J, Zhou K, Xiang Q, Zhang Y, Tan Z, Simoncini T, Fu X, Wang T. Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase. J Cell Mol Med. 2012;16(2):296-305.
46. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD. Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2001;17:615-675.
47. Li Q, Davila J, Kannan A, Flaws JA, Bagchi MK, Bagchi IC. Chronic exposure to bisphenol A affects uterine function during early pregnancy in mice. Endocrinology. 2016;157(5):1764-1774.
48. Miao M, Yuan W, Yang F, Liang H, Zhou Z, Li R, Gao E, Li DK. Associations between bisphenol A exposure and reproductive hormones among female workers. Int J Environ Res Public Health. 2015;12(10):13240-13250.
49. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol. 2008;70:23-49.
50. Liu GS, Morales A, Vafiadaki E, Lam CK, Cai WF, Haghighi K, Adly G, Hershberger RE, Kranias EG. A novel human R25Cphospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res. 2015; 107(1):164-174.
51. Knowlton AA, Sun L. Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. Am J Physiol Heart Circ Physiol. 2001;280(1):H455-H464.
52. Kararigas G, Becher E, Mahmoodzadeh S, Knosalla C, Hetzer R, Regitz-Zagrosek V. Sex-specific modification of progesterone receptor expression by 17b-oestradiol in human cardiac tissues. Biol Sex Differ. 2010;1(1):2.
53. Murphy JG, Khalil RA. Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther. 1999;291(1): 44-52.
54. la Sala A, Gadina M, Kelsall BLG. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J Immunol. 2005;175(5):2994-2999.
55. Murga C, Laguinge L, Wetzker R, Cuadrado A, Gutkind JS. Activation of Akt/protein kinase B by G protein-coupled receptors: A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma. J Biol Chem. 1998;273(30):19080-19085.
56. Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, Lakatta EG, Crow MT. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 30-kinase. Circ Res. 2000;87(12): 1172-1179.
57. Hsu SP, Chen TH, Chou YP, Chen LC, Kuo CT, Lee TS, Lin JJ, Chang NC, Lee WS. Extra-nuclear activation of progesterone receptor in regulating arterial smooth muscle cell migration. Atherosclerosis. 2011;217(1):83-89.
58. Suh BC, Hille B. PIP2 is a necessary cofactor for ion channel function: How and why? Annu Rev Biophys. 2008;37:175-195.
59. Meyer T, Wellner-Kienitz MC, Biewald A, Bender K, Eickel A, Pott L. Depletion of phosphatidylinositol 4, 5-bisphosphate by activation of phospholipase C-coupled receptors causes slow inhibition but not desensitization of G protein-gated inward rectifier K+ current in atrial myocytes. J Biol Chem. 2001;276(8):5650-5658.
60. Jung SR, Seo JB, Deng Y, Asbury CL, Hille B, Koh DS. Contributions of protein kinases and b-arrestin to termination of protease-activated receptor 2 signaling. J Gen Physiol. 2016;147(3):255-271.
61. Xu C, Watras J, Loew LM. Kinetic analysis of receptor-activated phosphoinositide turnover. J Cell Biol. 2003;161(4):779-791.
62. Hardie RC, Gu Y, Martin F, Sweeney ST, Raghu P. In vivo lightinduced and basal phospholipase C activity in Drosophila photoreceptors measured with genetically targeted phosphatidylinositol 4, 5-bisphosphate-sensitive ion channels (Kir2. 1). J Biol Chem. 2004;279(46):47773-47782.
63. Monet M, Francoeur N, Boulay G. Involvement of phosphoinositide 3-kinase and PTEN protein in mechanism of activation of TRPC6 protein in vascular smooth muscle cells. J Biol Chem. 2012; 287(21):17672-17681.
64. Zhang C, Bosch MA, Rønnekleiv OK, Kelly MJ. Kisspeptin activation of TRPC4 channels in female GnRH neurons requires PIP2 depletion and cSrc kinase activation. Endocrinology. 2013;154(8): 2772-2783.
65. Zhao FL, Herness S. Resynthesis of phosphatidylinositol 4, 5-bisphosphate mediates adaptation of the caffeine response in rat taste receptor cells. J Physiol. 2009;587(2):363-377.
66. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002; 57:257-275.
67. Andrikopoulos GK, Tzeis SE, Pipilis AG, Richter DJ, Kappos KG, Stefanadis CI, Toutouzas PK, Chimonas ET; investigators of the Hellenic Study of AMI. Younger age potentiates post myocardial infarction survival disadvantage of women. Int J Cardiol. 2006; 108(3):320-325.
68. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999;341(4):217-225.
69. Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Køber L, Connolly SJ, Marchant B, Camm J. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: A combined analysis from multicentre trials. Eur Heart J. 2005;26(14):1385-1393.
70. Barakat K, Wilkinson P, Suliman A, Ranjadayalan K, Timmis A. Acute myocardial infarction in women: Contribution of treatment variables to adverse outcome. Am Heart J. 2000;140(5):740-746.